This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Chaulin AM, Duplyakov DV. Increased natriuretic peptides not associated with heart failure. Russ. J. Cardiol. 2020;25:4140.Search in Google Scholar
Cao Z, Jia Y, Zhu B. BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine. Int J Mol Sci. 2019;20(8):1820Search in Google Scholar
Tofler G, Kopel E, Klempfner R, Eldar M, Buckley T, Goldenberg I. Triggers and timing of acute coronary syndrome. Coronary artery dis. 2017;119(10): p1560-5.Search in Google Scholar
Pimple P, Lima B, Hammadah M, Wilmot K, Ramadan R, Leventsevych, et al. Psychological Distress and Subsequent Cardiovascular Events in Individuals With Coronary Artery Disease. Am Heart J. 2019;8:e011866Search in Google Scholar
Wouters LT, Zwart DL, Erkelens DC, Cheung NS, de Groot E, Damoiseaux RA, et al. Chest discomfort at night and risk of acute coronary syndrome: cross-sectional study of telephone conversations. Fam Pract. 2020;37(4):473-478.Search in Google Scholar
Berge K, Brynildsen J, Røysland R, Strand H, Christensen G, Høiseth AD, et al. Prognostic value of cardiac biomarkers and National Early Warning Score 2 in acute dyspnoea. Open Heart. 2022;9(1):e001938.Search in Google Scholar
Rahmani R, Shafiee A, Parazaran K, Reshadati N. Predictive value of N-terminal-Pro brain natriuretic peptide in the detection of coronary artery disease in patients with positive myocardial perfusion imaging. Med J Islam Repub Iran. 2019;33:14.Search in Google Scholar
Gupta A, Beig JR, Tramboo NA, Afroze D, Hafeez I, Rather HA. The effect of percutaneous coronary revascularization on plasma N-terminal pro-B-type natriuretic peptide levels in stable coronary artery disease. Indian Heart J. 2018;70(2):282-288.Search in Google Scholar
Salama RH, El-Moniem AE, El-Hefney N, Samor T. NTerminaL PRO-BNP in Acute Coronary Syndrome Patients with ST Elevation Versus Non ST Elevation in Qassim Region of Saudi Arabia. Int J Health Sci (Qassim). 2011;5(2):136-45.Search in Google Scholar
Sterling MR, Durant RW, Bryan J, Levitan E, Brown T, Khodneva Y, et al. N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study. BMC Cardiovasc Disord 2018;18:66.Search in Google Scholar
Sarak T, Karadeniz M.The relationship between serum NT-proBNP levels and severity of coronary artery disease assessed by SYNTAX score in patients with acute myocardial infarction. Turk J Med Sci. 2019;49:1366-1373Search in Google Scholar
Goetze JP, Gore A, Møller CH, Steinbrüchel DA, Rehfeld JF, Nielsen LB. Acute myocardial hypoxia increases BNP gene expression. FASEB J. 2004;18(15):1928-30.Search in Google Scholar
WeidmannA, Klanke B, Wagner M, Volk T, Willam C, Wiesener MS, et al. Hypoxia, via stabilization of the hypoxia- inducible factor HIF-1α, is a direct and sufficient stimulus for brain-type natriuretic peptide inductionBiochem. J. 2008; 409 (233–242)Search in Google Scholar
Jarai R, Kaun C, Weiss TW, Speidi W, Richi K, Maurer G, et al. Human cardiac fibroblasts express Btype natriuretic peptide: fluvastatin ameliorates its upregulation by interleukin-1alpha, tumor necrosis factoralpha and transforming growth factor-beta. J. Cell. Mol. Med. 2013; 13(11-12):4415-21Search in Google Scholar
Arjamaa O, Nikinmaa M. Hypoxia regulates the natriuretic peptide system. Int. J. Physiol. Pathophysiol. Pharmacol. 2011;3:191–201.Search in Google Scholar
Goetze JP, Bruneau BG, Ramos HR, Ogawa T, de Bold MK, de Bold AJ et al. Cardiac natriuretic peptides. Nat Rev Cardiol. 2020;17(11):698-717Search in Google Scholar
Rautureau Y, Baxter GF. Acute actions of natriuretic peptides in coronary vasculature and ischaemic myocardium. Curr Pharm Des. 2004;10(20):2477-82.Search in Google Scholar
Kurt IH, Batur MK, Unal I. The effect of streptokinase therapy in STEMI and conventional therapy in NSTEMI patients on TIMI risk index, B-type natriuretic peptide and high-sensitive C-reactive protein. Anatol. J. Cardiol. 2011; 11(6):530-5.Search in Google Scholar
Ogawa A, Seino Y, Yamashita T, Ogata K, Takano T. Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST elevation vs non-ST elevation acute coronary syndrome. Circ J. 2006;70(11):1372-8.Search in Google Scholar
Drewniak W, Snopek G, Zarukiewicz M, Borys M, Dabrowski M. Prognostic value of the N-terminal pro- B-type natriuretic peptide in the elderly with acute myocardial infarction. Kardiol Pol. 2008; 66(7): 750-7.Search in Google Scholar
Buchner S, Debl K, Barlage S, Griese D, Fredersdorf S, Jeron A,et al. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome. Clin Chem Lab Med. 2010; 48:875–81.Search in Google Scholar
Mathbout M, Asfour A, Leung S, Lolay G, Idris A, Abdel-Latif A, Ziada KM. NT-proBNP Level Predicts Extent of Myonecrosis and Clinical Adverse Outcomes in Patients with ST-Elevation Myocardial Infarction: A Pilot Study. Med Res Arch. 2020;8(2):10.18103/mra.v8i2.2039.Search in Google Scholar
Fabris E, Ten Berg JM, Hermanides RS, Ottervanger JP, Dambrink JHE, Gosselink AM, et al. NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: Insight from the On-TIME II trial. Am Heart J. 2021;233:78-85Search in Google Scholar
Marjanovic D, Miljkovic J, Stanetic B. Assessment of Prognostic Markers of Heart Failure Following Acute Myocardial Infarction in Patients Treated With Primary Percutaneous Coronary Intervention. Scr Med 2022;53(2):125-9Search in Google Scholar
Redfors B, Chen S, Crowley A, Ben-Yehuda O, Gersh BJ, Lembo NJ, et al. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial. Circulation. 2018;138(5):469-478.Search in Google Scholar
Neyou A, O’Neil B, Berman AD, Boura JA, McCullough PA. et al. Determinants of markedly increased B-type natriuretic peptide in patients with STsegment elevation myocardial infarction. Am J Emerg Med. 2011; 29(2): 141–7.Search in Google Scholar
Chang AY, Abdullah SM, Jain T, Stanek HG, Das SR, McGuire DK, et al. Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study. J Am CollCardiol. 2007; 49(1):109-16.Search in Google Scholar
